RPRX — Royalty Pharma plc
Nasdaq ·
Materials ·
Chemicals ·
CIK 1802768 ·
Last close
$50.79
52W High
$51.65
52W Low
$31.43
ADV30
3,140,890
Last filing
2026-05-06
SIC
2834
No quarterly fundamentals indexed for this ticker.
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$2,611,980,000
Investing CF
$-2,595,962,000
Financing CF
$-517,343,000
CapEx
—
Dividends Paid
$-387,386,000
Buybacks
$-568,702,000
EPS Diluted TTM
$1.65
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$2,507,091,000
Inventory
—
Receivables
$27,511,000
ST Investments
$801,744,000
EBIT TTM
$1,695,140,000
Pretax Income TTM
$1,359,015,000
Interest Exp TTM
$336,125,000
Analysts
8
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,441,192,960
EBITDA
—
Free Cash Flow
—
Enterprise Value
$33,330,098,176
Total Cash
$637,496,000
Total Debt
$8,970,174,464
Shares Out
443,274,104
Trailing EPS
$1.90
Book Value
$15.11
ROE
—
ROA
—
Div Yield
1.85%
Recent Insider Activity
No insider activity indexed for this ticker.